Most cited
- Page Path
-
- HOME
- BROWSE ARTICLES
- Most cited
- Original Article
- Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
- Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo
- Clin Mol Hepatol. 2023;29(3):721-732. Published online March 22, 2023
-
View: 26157 Download: 1,696 Web of Science: 339 Crossref: 349
- Review
- Global incidence and prevalence of nonalcoholic fatty liver disease
- Margaret LP Teng, Cheng Han Ng, Daniel Q. Huang, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Eunice Tan, Mark D. Muthiah
- Clin Mol Hepatol. 2023;29(Suppl):S32-S42. Published online December 14, 2022
-
View: 20576 Download: 686 Web of Science: 292 Crossref: 328
- MAFLD: How is it different from NAFLD?
- Cameron Gofton, Yadhavan Upendran, Ming-Hua Zheng, Jacob George
- Clin Mol Hepatol. 2023;29(Suppl):S17-S31. Published online November 29, 2022
-
View: 26861 Download: 1,492 Web of Science: 212 Crossref: 219
- Non-alcoholic fatty liver disease: Definition and subtypes
- Seul Ki Han, Soon Koo Baik, Moon Young Kim
- Clin Mol Hepatol. 2023;29(suppl):S5-S16. Published online December 28, 2022
-
View: 12322 Download: 613 Web of Science: 109 Crossref: 113
- Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
- Kuei-Chuan Lee, Pei-Shan Wu, Han-Chieh Lin
- Clin Mol Hepatol. 2023;29(1):77-98. Published online October 13, 2022
-
View: 16282 Download: 809 Web of Science: 103 Crossref: 110
- Special Review
- Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity
- Gi-Ae Kim, Joon Ho Moon, Won Kim
- Clin Mol Hepatol. 2023;29(4):831-843. Published online August 25, 2023
-
View: 7040 Download: 407 Web of Science: 74 Crossref: 78
- Review
- Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective
- Diyang Xie, Jieyi Shi, Jian Zhou, Jia Fan, Qiang Gao
- Clin Mol Hepatol. 2023;29(2):206-216. Published online December 22, 2022
-
View: 10971 Download: 539 Web of Science: 82 Crossref: 74
- Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
- Do Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, Irsan Hasan, Lyana Setiawan, Ming-Lung Yu, Namiki Izumi, Nguyen Nguyen Huyen, Pierce Kah-Hoe Chow, Rosmawati Mohamed, Stephen Lam Chan, Tawesak Tanwandee, Teng-Yu Lee, Thi Thanh Nguyen Hai, Tian Yang, Woo-Chang Lee, Henry Lik Yuen Chan
- Clin Mol Hepatol. 2023;29(2):277-292. Published online January 30, 2023
-
View: 11190 Download: 651 Web of Science: 74 Crossref: 74
- Epidemiology of metabolic dysfunction-associated steatotic liver disease
- Zobair M. Younossi, Markos Kalligeros, Linda Henry
- Clin Mol Hepatol. 2025;31(Suppl):S32-S50. Published online August 19, 2024
-
View: 15030 Download: 1,973 Web of Science: 64 Crossref: 67
- Editorial
- The latest global burden of liver cancer: A past and present threat
- Joo Hyun Oh, Dae Won Jun
- Clin Mol Hepatol. 2023;29(2):355-357. Published online March 9, 2023
-
View: 7351 Download: 148 Web of Science: 60 Crossref: 65
- Review
- Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
- Peter Konyn, Aijaz Ahmed, Donghee Kim
- Clin Mol Hepatol. 2023;29(Suppl):S43-S57. Published online November 22, 2022
-
View: 6810 Download: 208 Web of Science: 57 Crossref: 58
- Recent advances in the management of hepatocellular carcinoma
- Kamya Sankar, Jun Gong, Arsen Osipov, Steven A. Miles, Kambiz Kosari, Nicholas N. Nissen, Andrew E. Hendifar, Ekaterina K. Koltsova, Ju Dong Yang
- Clin Mol Hepatol. 2024;30(1):1-15. Published online July 21, 2023
-
View: 10047 Download: 456 Web of Science: 52 Crossref: 51
- Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
- Shang-Chin Huang, Chun-Jen Liu
- Clin Mol Hepatol. 2023;29(2):320-331. Published online February 1, 2023
-
View: 8967 Download: 482 Web of Science: 45 Crossref: 50
- Risk factors in nonalcoholic fatty liver disease
- Eunji Ko, Eileen L. Yoon, Dae Won Jun
- Clin Mol Hepatol. 2023;29(Suppl):S79-S85. Published online December 14, 2022
-
View: 6791 Download: 273 Web of Science: 42 Crossref: 46
- Interaction between sarcopenia and nonalcoholic fatty liver disease
- Sae Kyung Joo, Won Kim
- Clin Mol Hepatol. 2023;29(Suppl):S68-S78. Published online December 5, 2022
-
View: 7818 Download: 344 Web of Science: 43 Crossref: 43
- Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison
- Yuri Cho, Bo Hyun Kim, Joong-Won Park
- Clin Mol Hepatol. 2023;29(2):252-262. Published online March 10, 2023
-
View: 6526 Download: 302 Web of Science: 41 Crossref: 43
- Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
- Chih-Lin Lin, Jia-Horng Kao
- Clin Mol Hepatol. 2023;29(3):605-622. Published online February 15, 2023
-
View: 7468 Download: 358 Web of Science: 42 Crossref: 42
- Special Review
- Waiting for the changes after the adoption of steatotic liver disease
- Eileen L. Yoon, Dae Won Jun
- Clin Mol Hepatol. 2023;29(4):844-850. Published online September 6, 2023
-
View: 4233 Download: 187 Web of Science: 35 Crossref: 42
- Original Article
- Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study
- Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith
- Clin Mol Hepatol. 2023;29(2):433-452. Published online January 4, 2023
-
View: 8738 Download: 273 Web of Science: 41 Crossref: 41
- Review
- Development and prognosis of hepatocellular carcinoma in patients with diabetes
- Takuma Nakatsuka, Ryosuke Tateishi
- Clin Mol Hepatol. 2023;29(1):51-64. Published online July 29, 2022
-
View: 7326 Download: 270 Web of Science: 38 Crossref: 39
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
Video abstract
-
- Modulation of lymphatic vessels in management of liver disease and complications
- Metabolic dysfunction-associated steatotic liver disease across women’s reproductive lifespan and issues
- Examining the therapeutic landscape of beta-blockers in portal hypertension
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor14.0First decision
07 Days
Publication after acceptance
04 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2023-2025)
|
|||||||
